DD243642A5 - Hustenlinderungsmittel - Google Patents
Hustenlinderungsmittel Download PDFInfo
- Publication number
- DD243642A5 DD243642A5 DD85281661A DD28166185A DD243642A5 DD 243642 A5 DD243642 A5 DD 243642A5 DD 85281661 A DD85281661 A DD 85281661A DD 28166185 A DD28166185 A DD 28166185A DD 243642 A5 DD243642 A5 DD 243642A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- composition
- carrier material
- item
- effect
- active ingredients
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims abstract description 42
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- 239000010642 eucalyptus oil Substances 0.000 claims abstract description 14
- 229940044949 eucalyptus oil Drugs 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- 235000003351 Brassica cretica Nutrition 0.000 claims abstract description 11
- 235000003343 Brassica rupestris Nutrition 0.000 claims abstract description 11
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000010460 mustard Nutrition 0.000 claims abstract description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 5
- 230000002195 synergetic effect Effects 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract 3
- 244000056139 Brassica cretica Species 0.000 claims abstract 2
- 239000012876 carrier material Substances 0.000 claims description 17
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 239000011505 plaster Substances 0.000 claims description 7
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- -1 • bandage Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000002209 hydrophobic effect Effects 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims 1
- 239000004753 textile Substances 0.000 claims 1
- 206010011224 Cough Diseases 0.000 abstract description 16
- 235000015277 pork Nutrition 0.000 abstract description 8
- 230000000954 anitussive effect Effects 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 6
- 238000013268 sustained release Methods 0.000 abstract description 2
- 239000012730 sustained-release form Substances 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 22
- 241000219198 Brassica Species 0.000 description 9
- 206010006451 bronchitis Diseases 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 229920000915 polyvinyl chloride Polymers 0.000 description 7
- 239000004800 polyvinyl chloride Substances 0.000 description 7
- 208000006673 asthma Diseases 0.000 description 5
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000011241 protective layer Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 229960004126 codeine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010011225 Cough decreased Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 206010044314 Tracheobronchitis Diseases 0.000 description 1
- 206010056397 Tracheomalacia Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000002019 doping agent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940066366 other cough suppressants in atc Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU823048A HU187414B (en) | 1984-10-12 | 1984-10-12 | Process for producing cough-preparation of physiologically relieving and sedative effect, fixable on skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD243642A5 true DD243642A5 (de) | 1987-03-11 |
Family
ID=10962279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD85281661A DD243642A5 (de) | 1984-10-12 | 1985-10-11 | Hustenlinderungsmittel |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0198003A1 (da) |
| DD (1) | DD243642A5 (da) |
| DK (1) | DK277486A (da) |
| HU (1) | HU187414B (da) |
| WO (1) | WO1986002270A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4433191A1 (de) * | 1994-09-17 | 1996-03-21 | Lohmann Therapie Syst Lts | Selbstklebendes Pflaster zur Abgabe von Wirkstoff an die Umgebung eines Trägers |
| RU2125855C1 (ru) * | 1996-10-08 | 1999-02-10 | Открытое акционерное общество Волгоградский маслоэкстракционный завод "Сарепта" | Горчичник |
| IN183330B (da) * | 1998-03-23 | 1999-11-20 | Dalmia Ct For Biotechnology | |
| AU2000250055A1 (en) * | 2000-04-13 | 2001-10-30 | Lectec Corporation | Therapeutic patch containing a liquid or gel organic compound as a carrier |
| US20040071757A1 (en) * | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
| CN104971322A (zh) * | 2015-06-11 | 2015-10-14 | 钟兴欢 | 一种黄皮清咽润喉片 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB190719133A (en) * | 1907-08-26 | 1908-05-07 | William Bryant | An Improved Ointment |
| AT261811B (de) * | 1963-11-18 | 1968-05-10 | Sophie Lintner | Verfahren zur Herstellung einer homogenen Salbe |
-
1984
- 1984-10-12 HU HU823048A patent/HU187414B/hu not_active IP Right Cessation
-
1985
- 1985-10-11 DD DD85281661A patent/DD243642A5/de not_active IP Right Cessation
- 1985-10-11 EP EP85905100A patent/EP0198003A1/en not_active Withdrawn
- 1985-10-11 WO PCT/HU1985/000060 patent/WO1986002270A1/en not_active Ceased
-
1986
- 1986-06-12 DK DK277486A patent/DK277486A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1986002270A1 (en) | 1986-04-24 |
| EP0198003A1 (en) | 1986-10-22 |
| HU187414B (en) | 1986-01-28 |
| DK277486D0 (da) | 1986-06-12 |
| DK277486A (da) | 1986-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68910520T2 (de) | Verfahren zur Verminderung von Hautirritationen bei Anwendung von durchdringungsverstärkenden Arzneimittelzusammensetzungen. | |
| DE3789617T2 (de) | Glycerolmonolaurate enthaltende, die Hautpermeabilität vergrössernde Zusammensetzungen. | |
| DE69716271T2 (de) | Zusammensetzungen enthaltend lidocain und emu-öl und verwendungsmethoden | |
| DE69326461T2 (de) | Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung | |
| DE69401945T2 (de) | Einarbeitung eines poly-n-vinylamids in ein transdermales system | |
| DE69521512T2 (de) | Neues pharmazeutisches präparat zur schmerzbehandlung | |
| DE69320242T2 (de) | Medizinische Selbstklebefolie und Arzneimittelzubereitung | |
| EP2744474B1 (de) | Medizinische hautschutz-zusammensetzung mit einer die hautbarriere verbessernden wirkstoffkombination | |
| DE3131610A1 (de) | "auflage mit einem gehalt an mikroverkapseltem nitroglyzerin, die zur perkutanten verabreichung von nitroglyzerin geeignet ist" | |
| CH668188A5 (en) | Corticosteroid ointment compsns. - comprise e.g. dexamethasone in poly:alkylene glycol base, and are used esp. for treating rhinitis | |
| DE19548332A1 (de) | Hormonpflaster | |
| CA2384679A1 (en) | Using quaternary ammonium salts for transdermal drug delivery | |
| DD223359A5 (de) | Verfahren zur herstellung eines perkutanen pharmazeutischen praeparates | |
| DE69027220T2 (de) | Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen | |
| WO1992020339A1 (de) | Mittel zur transdermalen applikation enthaltend ergolin-derivate | |
| DE19950066A1 (de) | Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut | |
| DE2356098C3 (de) | Zusammensetzung für Umschläge | |
| EP0584126B1 (de) | Lanolinderivate als penetrationsfördernde substanzen | |
| EP1713522A1 (de) | Wundauflage und wundschnellverband mit einem vasokonstriktorischen inhaltstoff | |
| DE3836862A1 (de) | Mittel zur transdermalen applikation von steroidhormonen | |
| CA2063127C (en) | Reduction in cutaneous atrophy | |
| DD243642A5 (de) | Hustenlinderungsmittel | |
| DE69530832T2 (de) | Transdermales abgabesystem, das ein östrogen enthält | |
| DE3438005A1 (de) | Pharmazeutisches mittel zur lokalen therapie der psoriasis | |
| EP1171105A1 (de) | Transdermales therapeutisches system mit einem stark wirksamen neuroleptikum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |